290 related articles for article (PubMed ID: 26791964)
41. [Fine needle aspiration cytology of eyelid sebaceous gland carcinoma and its differential diagnosis].
Gao L; Lin WH; Gong ZJ; Liu Y; Liu YM; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):36-9. PubMed ID: 14989926
[TBL] [Abstract][Full Text] [Related]
42. Sebaceous carcinoma of lid margin masquerading as cutaneous horn.
Brauninger GE; Hood CI; Worthen DM
Arch Ophthalmol; 1973 Nov; 90(5):380-1. PubMed ID: 4746090
[No Abstract] [Full Text] [Related]
43. Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis.
Wolfe JT; Yeatts RP; Wick MR; Campbell RJ; Waller RR
Am J Surg Pathol; 1984 Aug; 8(8):597-606. PubMed ID: 6465419
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
[TBL] [Abstract][Full Text] [Related]
45. Immunohistological Localization of Peroxisome Proliferator-Activated Receptor α and γ in Human Sebaceous Glands.
Furue M; Takemura M; Nishio K; Sato Y; Nagata S; Kan N; Suenaga A; Furue K; Yoshida M; Konishi S; Tsuji G
Fukuoka Igaku Zasshi; 2016 Nov; 107(11):199-203. PubMed ID: 29227070
[TBL] [Abstract][Full Text] [Related]
46. Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control.
Takahashi Y; Takahashi E; Nakakura S; Kitaguchi Y; Mupas-Uy J; Kakizaki H
Am J Ophthalmol; 2016 Nov; 171():67-74. PubMed ID: 27590119
[TBL] [Abstract][Full Text] [Related]
47. Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid.
Rigas PK; Kase S; Rao NA
Eur J Ophthalmol; 2009; 19(5):702-7. PubMed ID: 19787585
[TBL] [Abstract][Full Text] [Related]
48. Does β-catenin have a role in pathogenesis of sebaceous cell carcinoma of the eyelid?
Jayaraj P; Sen S; Kashyap S; Sharma A; Pushker N; Bajaj MS; Ghose S; Chosdol K
Br J Ophthalmol; 2011 Feb; 95(2):284-7. PubMed ID: 20813740
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
50. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
51. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
[TBL] [Abstract][Full Text] [Related]
52. [Sebaceous gland adenoma of the eyelid].
Shlopova NB; Shlopov VG
Vestn Oftalmol; 1989; 105(5):76-8. PubMed ID: 2595908
[No Abstract] [Full Text] [Related]
53. Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma.
Nakopoulou L; Mylona E; Papadaki I; Kapranou A; Giannopoulou I; Markaki S; Keramopoulos A
Pathobiology; 2005; 72(5):241-9. PubMed ID: 16374068
[TBL] [Abstract][Full Text] [Related]
54. Ocular Sebaceous Carcinoma In Situ With Biphenotypic Differentiation: A Reappraisal of the Alternative Origin of the Tumor.
Yim CL; Lam SC; Yuen HKL; Cheuk W
Int J Surg Pathol; 2020 Dec; 28(8):888-892. PubMed ID: 32363990
[TBL] [Abstract][Full Text] [Related]
55. Sebaceoma of the eyelid: a rare entity.
Mittal R; Tripathy D
Can J Ophthalmol; 2014 Jun; 49(3):e78-80. PubMed ID: 24862791
[No Abstract] [Full Text] [Related]
56. 15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa.
Shappell SB; Keeney DS; Zhang J; Page R; Olson SJ; Brash AR
J Invest Dermatol; 2001 Jul; 117(1):36-43. PubMed ID: 11442747
[TBL] [Abstract][Full Text] [Related]
57. Sebaceous gland carcinoma of the eyelid.
Perlman E; McMahon RT
Am J Ophthalmol; 1978 Nov; 86(5):699-703. PubMed ID: 717528
[TBL] [Abstract][Full Text] [Related]
58. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
[TBL] [Abstract][Full Text] [Related]
59. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
60. Sebaceous gland carcinoma. Review of 40 cases.
Doxanas MT; Green WR
Arch Ophthalmol; 1984 Feb; 102(2):245-9. PubMed ID: 6696670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
